JOIN THE gMG COMMUNITY FOR A VIRTUAL EVENT!

VYVGART: WE RISE TOGETHER

Learn about VYVGART—the first and only FDA-approved treatment of its kind for adults with anti-AChR antibody positive gMG 

AChR=acetylcholine receptor
gMG=generalized myasthenia gravis
Visit VYVGART.com/glossary for a glossary of terms.

Wednesday, March 16

Three viewing times!

11:00 AM | 2:00 PM | 8:30 PM EST

  • Hear questions from the gMG community answered by experts who are knowledgeable about VYVGART
  • Explore the VYVGART clinical trial results with two physicians who worked on the trial
  • Learn how VYVGART works from an argenx lead scientist who helped discover this new treatment option

RSVP NOW

When added to their current gMG treatment, VYVGART helped clinical trial participants with anti-AChR antibody positive gMG achieve improved daily abilities

68% (44 of 65) of participants on VYVGART achieved significant improvement in their ability to perform daily activities*

*Improvement maintained for 4 or more weeks was measured by a decrease of 2 or more points on the Myasthenia Gravis Activities of Daily Living (MG-ADL) scale, with the first reduction occurring no later than 1 week after the last infusion of treatment cycle 1. The MG-ADL scale assesses the impact of gMG on daily functions by measuring 8 signs or symptoms that are commonly affected in gMG. Each item is measured on a 4-point scale, where a score of 0 represents normal function and a score of 3 represents the loss of ability to perform that function. Total scores range from 0 to 24 points, with a higher score showing more severe gMG.

Get more details about this upcoming event! 

VYVGART Q&A panel

Two neurologists and a Nurse Case Manager dive deeper into important questions from the gMG community. They’ll discuss clinical trial results, symptom tracking, common side effects, dosing information, and more!

  

Learn the science
behind VYVGART

MOA illustration

An argenx lead scientist explains how VYVGART works, and a neurologist who helped run the clinical trial shares its results.

Enjoy a special performance for the  community 

close up on stringed instrument

A classical string sextet caps off the virtual event with an uplifting musical finale accompanied by a beautiful visual display.

“I am optimistic that VYVGART will change the way we treat this debilitating disease.”

—Dr. Tuan Vu, a neurologist who worked on the VYVGART clinical trial

Sign up for We Rise Together!

This virtual event explores VYVGART, the first and only FDA-approved treatment of its kind for adults with anti-AChR antibody positive generalized myasthenia gravis.

Already signed up? Go to the event platform.

Sign up here for We Rise Together!

When you sign up for the virtual event, you’ll also get the latest updates and information about VYVGART via email.

*indicates required field.

agreement
Privacy

Thank you, #!

Let your friends know you’re attending.

SHARE WITH FRIENDS

 

Here’s how to access the We Rise Together virtual event:

  • In a few minutes, you will receive an email with a link you will use to join We Rise Together on March 16
  • On the day of We Rise Together, check your inbox for a reminder email containing a link to the event
  • Need any help on the day of the event? Reach out to Experience Welcome, the team hosting We Rise Together, at support@experiencewelcome.com

If you have a minute, please tell us a little more about yourself. Filling out this information is optional and not required to attend the We Rise Together virtual event and receive VYVGART updates. You have already signed up for email updates.

Mailing address 

Sharing this information will help us send you the latest VYVGART updates and information based on where you live in the country. 


By submitting this form, you confirm that you are at least 18 years of age and live in the United States.

Thanks for signing up!

Here’s how to access the We Rise Together virtual event:

  • In a few minutes, you will receive an email with a link you will use to join We Rise Together on March 16
  • On the day of We Rise Together, check your inbox for a reminder email containing a link to the event
  • Need any help on the day of the event? Reach out to Experience Welcome, the team hosting We Rise Together, at support@experiencewelcome.com

Click the button below to invite your family and friends. We can’t wait to see you all there!

SHARE WITH FRIENDS

Additional Resources

How VYVGART may help

Explore the efficacy and safety results from the VYVGART clinical trial.

How VYVGART works

Because of VYVGART, IgG antibodies are reduced, including the harmful AChR antibodies that cause gMG symptoms.

Talk to your neurologist

The VYVGART Doctor Discussion Guide can be used to help you discuss with your neurologist current anti-AChR antibody positive gMG symptoms you have and how they impact your daily abilities.

IgG=immunoglobulin G
Visit VYVGART.com/glossary for a glossary of terms.

VYVGART (efgartigimod alfa-fcab)
VYVGART (efgartigimod alfa-fcab)

Picture your life in motion

What is the most important information I should know about VYVGART® (efgartigimod alfa-fcab)?

VYVGART may cause serious side effects, including:

  • Infection. VYVGART may increase the risk of infection. In a clinical study, the most common infections were urinary tract and respiratory tract infections. More patients on VYVGART vs placebo had below normal levels for white blood cell counts, lymphocyte counts, and neutrophil counts. The majority of infections and blood side effects were mild to moderate in severity. Your health care provider should check you for infections before starting treatment, during treatment, and after treatment with VYVGART. Tell your health care provider if you have any history of infections. Tell your health care provider right away if you have signs or symptoms of an infection during treatment with VYVGART such as fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain.
  • Undesirable immune reactions (hypersensitivity reactions). VYVGART can cause the immune system to have undesirable reactions such as rashes, swelling under the skin, and shortness of breath. In clinical studies, the reactions were mild or moderate and occurred within 1 hour to 3 weeks of administration, and the reactions did not lead to VYVGART discontinuation. Your health care provider should monitor you during and after treatment and discontinue VYVGART if needed. Tell your health care provider immediately about any undesirable reactions.

Before taking VYVGART, tell your health care provider about all of your medical conditions, including if you:

  • Have a history of infection or you think you have an infection
  • Have received or are scheduled to receive a vaccine (immunization). Discuss with your health care provider whether you need to receive age-appropriate immunizations before initiation of a new treatment cycle with VYVGART. The use of vaccines during VYVGART treatment has not been studied, and the safety with live or live-attenuated vaccines is unknown. Administration of live or live-attenuated vaccines is not recommended during treatment with VYVGART.
  • Are pregnant or plan to become pregnant and are breastfeeding or plan to breastfeed.

Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the common side effects of VYVGART?

The most common side effects of VYVGART are respiratory tract infection, headache, and urinary tract infection.

These are not all the possible side effects of VYVGART. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.

What is VYVGART?

VYVGART is a prescription medicine used to treat a condition called generalized myasthenia gravis, which causes muscles to tire and weaken easily throughout the body, in adults who are positive for antibodies directed toward a protein called acetylcholine receptor (anti-AChR antibody positive).

Please see the full Prescribing Information for VYVGART and talk to your doctor.

What is the most important information I should know about VYVGART® (efgartigimod alfa-fcab)?

VYVGART may cause serious side effects, including:

  • Infection. VYVGART may increase the risk of infection. In a clinical study, the most common infections were urinary tract and respiratory tract infections. More patients on VYVGART vs placebo had below normal levels for white blood cell counts, lymphocyte counts, and neutrophil counts. The majority of infections and blood side effects were mild to moderate in severity. Your health care provider should check you for infections before starting treatment, during treatment, and after treatment with VYVGART. Tell your health care provider if you have any history of infections. Tell your health care provider right away if you have signs or symptoms of an infection during treatment with VYVGART such as fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain.
  • Undesirable immune reactions (hypersensitivity reactions). VYVGART can cause the immune system to have undesirable reactions such as rashes, swelling under the skin, and shortness of breath. In clinical studies, the reactions were mild or moderate and occurred within 1 hour to 3 weeks of administration, and the reactions did not lead to VYVGART discontinuation. Your health care provider should monitor you during and after treatment and discontinue VYVGART if needed. Tell your health care provider immediately about any undesirable reactions.

Before taking VYVGART, tell your health care provider about all of your medical conditions, including if you:

  • Have a history of infection or you think you have an infection
  • Have received or are scheduled to receive a vaccine (immunization). Discuss with your health care provider whether you need to receive age-appropriate immunizations before initiation of a new treatment cycle with VYVGART. The use of vaccines during VYVGART treatment has not been studied, and the safety with live or live-attenuated vaccines is unknown. Administration of live or live-attenuated vaccines is not recommended during treatment with VYVGART.
  • Are pregnant or plan to become pregnant and are breastfeeding or plan to breastfeed.

Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the common side effects of VYVGART?

The most common side effects of VYVGART are respiratory tract infection, headache, and urinary tract infection.

These are not all the possible side effects of VYVGART. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.

What is VYVGART?

VYVGART is a prescription medicine used to treat a condition called generalized myasthenia gravis, which causes muscles to tire and weaken easily throughout the body, in adults who are positive for antibodies directed toward a protein called acetylcholine receptor (anti-AChR antibody positive).

Please see the full Prescribing Information for VYVGART and talk to your doctor.